comparemela.com

Latest Breaking News On - Canadian consortium for industrial research - Page 1 : comparemela.com

Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial

First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable pancreatic cancer. JERUSALEM, April 03,. | April 3, 2023

Israel generalMarie pierreYona keisariAlpha daDiane cotePascal fischerMiriam santos dutraPolytechnique montrItzhak kelsonCorey millerAlpha tau medical ltdMcgill universityProfessor of medicine at mcgill universityCentre for clinical epidemiologyCanadian consortium for industrial researchMcgill centre for translational research in cancer

Alpha Tau and the JGH Announce Alpha DaRT Treatment of

First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable.

United statesIsrael generalPolytechnique montrItzhak kelsonCorey millerAlpha daDiane cotePascal fischerYona keisariMiriam santos dutraInnovation in medical technologyCentre for nursing researchMcgill centre for translational research in cancerTransmedtech instituteTherapeutic endoscopy of the division gastroenterologyTerry fox molecular oncology group

New collaboration to improve the detection of type 2 diabetes in high-risk patients starts in Montreal, Quebec

/CNW Telbec/ - The Research Institute of the McGill University Health Centre (RI-MUHC), the McGill University Health Centre (MUHC) Foundation with Boehringer.

Anne coffeyAbhinav sharmaJulie quennevilleAndrea sambatiCanadian consortium for industrial researchBoehringer ingelheim canada ltdBrand communicationsOur dream big campaignBoehringer ingelheimDiabetes canada clinical practice guidelines expert committeeResearch instituteAnimal healthMcgill university health centreFaculty of medicine mcgill universityCanadian cardiovascular guidelineHuman pharma

BioMark Diagnostics, Inc : BioMark Receives $825K Grant to Develop Its Liquid Biopsy Assay for Lung Cancer Screening

Vancouver, British Columbia (Newsfile Corp. - June 1, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce today that its wholly-owned subsidiary

United kingdomBritish columbiaPhilippe joubertRashid ahmed buxQuebec respiratory health research networkInnovation in medical technologyCanadian cancer societyBiomark diagnostics incNovel technology applications in cancer preventionBrain canada foundationBiomark diagnostic solutions incCanadian consortium for industrial researchMinistry of economyBritish columbia newsfile corpConsortium for industrial researchPhytronix technologies inc

vimarsana © 2020. All Rights Reserved.